BioSpace News Archive

Sentinel Diagnostics Launches Two New Serological Tests To Quickly Assess The Immunoresponse To SARS-CoV-2

To quickly assess the immune response to SARS-CoV-2 of patients and entire communities, Sentinel Diagnostics announces the launch of two new serological tests for the detection of total antibodies to SARS-CoV-2 specific proteins in human serum: COVID-19 Anti-S1 Total Ab and COVID-19 Anti-NC Total Ab.

May 4, 2021
·
2 min read
Drug Development

HDT Bio, Gennova Biopharmaceuticals Announce First Healthy Volunteers Dosed in Phase I/II Trials Of Unique COVID-19 RNA Vaccine in India

HDT Bio’s RNA-based vaccine offers simpler manufacturing, easier deployment, and requires vastly lower dosing than current COVID-19 vaccines

May 4, 2021
·
2 min read
BioMidwest

American Lung Association Improves Lung Health of Americans with Better Breathers Network

During Asthma Awareness Month, Lung Association highlights new resources, support system for those with chronic lung disease

May 4, 2021
·
3 min read
Business

DexCare Appoints Toby Cosgrove, M.D. to Board Of Directors

Former President and Chief Executive Officer of Cleveland Clinic expands company’s health system experience and thought leadership

May 4, 2021
·
3 min read
Genetown

Insulet to Present at BofA Securities 2021 Virtual Healthcare Conference

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that management will present at the virtual BofA Securities 2021 Health Care Conference on Wednesday, May 12, 2021 at 4:15 p.m..

May 4, 2021
·
1 min read
Business

Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update

Innate Pharma SA, announced that the Company will hold a conference call on Thursday, May 11, 2021 at 3 p.m. CEST / 9 a.m. ET, to give an update on business progress during the first quarter of 2021.

May 4, 2021
·
4 min read
Nicox’s Licensee Bausch + Lomb Launches VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024% in Taiwan and Receives Approval in Qatar

Press Release Nicox’s Licensee Bausch + Lomb Launches VYZULTA®(latanoprostene bunod ophthalmic solution), 0.024%in Taiwan and Receives Approval in Qatar

May 4, 2021
·
3 min read
Deals

Relief and Applied Pharma Research (APR) Sign Binding Term Sheet for Relief to Acquire All Outstanding Shares of APR

Acquisition would further diversify Relief’s pipeline with both commercial products and clinical-stage programs

May 4, 2021
·
6 min read